newsfilter
← Latest News
Business Wire·

AngioDynamics and The PERT Consortium® Name Jacobi Hospital as ALPHA-PE Research Fund Award Recipient to Advance Real-World Pulmonary Embolism Evidence

Investigator-Led Study Will Evaluate Imaging Biomarkers That May Help Predict Thrombectomy Success and Inform Long-Term PE Care AngioDynamics, Inc. (NASDAQ:ANGO), a medical technology company focused on restoring